ACM Research, Inc.·4

Mar 9, 4:30 PM ET

Pappis Charles C 4

4 · ACM Research, Inc. · Filed Mar 9, 2026

Research Summary

AI-generated summary of this filing

Updated

ACM Research (ACMR) Director Charles Pappis Exercises Options, Sells 5,000 Shares

What Happened Charles C. Pappis, a director of ACM Research (ACMR), exercised 5,000 stock options on March 5, 2026 at an exercise price of $29.18 per share (total cost $145,900). He sold 5,000 shares the same day in an open-market transaction at $50.09 per share, generating gross proceeds of $250,450. The Form 4 shows the related derivative (the option) was converted/disposed upon exercise.

Key Details

  • Transaction date: March 5, 2026. Filing date: March 9, 2026 (timely — within 2 business days).
  • Exercise: 5,000 shares acquired at $29.18 each — total $145,900 (transaction code M).
  • Sale: 5,000 shares sold at $50.09 each — total proceeds $250,450 (transaction code S).
  • Footnotes: (F1) option exercise to purchase 5,000 shares; (F2) sale effected under a Rule 10b5-1 trading plan adopted Nov 20, 2025; (F3) option was fully vested and exercisable.
  • Shares owned after the transaction: not specified in the supplied filing.

Context

  • This was an exercise of vested options followed by an immediate sale of the acquired shares the same day — a common pattern that can be effectively a cashless exercise (convert option to shares then sell).
  • The sale was carried out under a pre-established 10b5-1 plan, which typically means the trades were pre-scheduled and not ad hoc market-timing decisions.
  • Filing was timely, and the transactions are routine insider activity; facts above are drawn directly from the Form 4.

Insider Transaction Report

Form 4
Period: 2026-03-05
Transactions
  • Exercise/Conversion

    Class A Common Stock

    [F1]
    2026-03-05$29.18/sh+5,000$145,9005,000 total
  • Sale

    Class A Common Stock

    [F2]
    2026-03-05$50.09/sh5,000$250,4500 total
  • Exercise/Conversion

    Stock Option

    [F1][F3]
    2026-03-055,0005,000 total
    Exercise: $29.18Exp: 2035-03-14Class A Common Stock (5,000 underlying)
Footnotes (3)
  • [F1]On March 5, 2026, the reporting person exercised a previously issued stock option to purchase 5,000 shares of Class A Common Stock of the Issuer.
  • [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.
  • [F3]The option is fully vested and exercisable.
Signature
/s/ Mark McKechnie, Attorney-in-Fact for Charles Pappis|2026-03-09

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4